These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9924432)

  • 1. Detection of oestrogen receptors in non-invasive and invasive transitional cell carcinomas of the urinary bladder using both conventional immunohistochemistry and the tyramide staining amplification (TSA) technique.
    Kaufmann O; Baume H; Dietel M
    J Pathol; 1998 Oct; 186(2):165-8. PubMed ID: 9924432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of antibodies against estrogen and progesterone receptors to identify metastatic breast and ovarian carcinomas by conventional immunohistochemical and tyramide signal amplification methods.
    Kaufmann O; Köther S; Dietel M
    Mod Pathol; 1998 Apr; 11(4):357-63. PubMed ID: 9578086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder.
    Tong GX; Yee H; Chiriboga L; Hernandez O; Waisman J
    Hum Pathol; 2005 Jul; 36(7):741-6. PubMed ID: 16084942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
    Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-cadherin immunoreactivity correlates with recurrence and progression of minimally invasive transitional cell carcinomas of the urinary bladder.
    Mahnken A; Kausch I; Feller AC; Krüger S
    Oncol Rep; 2005 Oct; 14(4):1065-70. PubMed ID: 16142373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel approach of human epidermal growth factor receptor 2 detection in noninvasive and invasive transitional cell carcinoma of the bladder.
    Hauser-Kronberger C; Peham K; Grall J; Rausch W; Hutarew G; Dietze O
    J Urol; 2006 Mar; 175(3 Pt 1):875-80; discussion 880. PubMed ID: 16469569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.
    Korkolopoulou P; Givalos N; Saetta A; Goudopoulou A; Gakiopoulou H; Thymara I; Thomas-Tsagli E; Patsouris E
    Hum Pathol; 2005 Aug; 36(8):899-907. PubMed ID: 16112007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential for molecular-targeted therapy targeting human epidermal growth factor receptor-2 for invasive bladder cancer.
    Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Inoue Y; Noguchi H; Honda N
    Oncol Rep; 2007 Jul; 18(1):3-7. PubMed ID: 17549338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridization.
    Matsubara H; Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Honda N
    Oncol Rep; 2008 Jan; 19(1):57-63. PubMed ID: 18097576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical demonstration of human chorionic gonadotropin in tumors of the urinary bladder.
    Yamase HT; Wurzel RS; Nieh PT; Gondos B
    Ann Clin Lab Sci; 1985; 15(5):414-7. PubMed ID: 3904591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A
    Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: a comparative analysis of clinicopathological features and survival outcomes according to receptor expression.
    Tuygun C; Kankaya D; Imamoglu A; Sertcelik A; Zengin K; Oktay M; Sertcelik N
    Urol Oncol; 2011; 29(1):43-51. PubMed ID: 19372057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of uPA and uPAR expression with invasive behaviors of urinary transitional cell carcinoma].
    Li YJ; Zheng BZ; Zhou ZL
    Ai Zheng; 2004 Jun; 23(6):704-6. PubMed ID: 15191676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor gamma expression in urothelial carcinomas of the bladder: association with differentiation, proliferation and clinical outcome.
    Mylona E; Giannopoulou I; Diamantopoulou K; Bakarakos P; Nomikos A; Zervas A; Nakopoulou L
    Eur J Surg Oncol; 2009 Feb; 35(2):197-201. PubMed ID: 18513919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma.
    Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
    J Urol; 2007 Feb; 177(2):481-7; discussion 487. PubMed ID: 17222615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The expression of urokinase-type plasminogen activator and its receptor in urinary transitional cell carcinoma].
    Li YJ; Zheng BZ; Zhou ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):57-9. PubMed ID: 14981816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features.
    Ramalingam P; Middleton LP; Tamboli P; Troncoso P; Silva EG; Ayala AG
    Ann Diagn Pathol; 2003 Apr; 7(2):112-9. PubMed ID: 12715337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of cathepsin B in transitional bladder carcinoma correlates with tumor invasion.
    Eiján AM; Sandes EO; Riveros MD; Thompson S; Pasik L; Mallagrino H; Celeste F; Casabé AR
    Cancer; 2003 Jul; 98(2):262-8. PubMed ID: 12872343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
    Zhou JT; Cai ZM; Li NC; Na YQ
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superficially invasive transitional cell carcinoma of the bladder associated with distant cutaneous metastases.
    Swick BL; Gordon JR
    J Cutan Pathol; 2010 Dec; 37(12):1245-50. PubMed ID: 19919656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.